GIP (Glucose-dependent Insulinotropic Polypeptide)
A second incretin hormone. Tirzepatide is a dual GLP-1/GIP agonist; semaglutide acts only on GLP-1.
Which Procedures Involve GIP?
GIP (Glucose-dependent Insulinotropic Polypeptide) appears in the following procedure guides on ProcedureFinder:
Frequently Asked Questions
What is GIP? +
A second incretin hormone. Tirzepatide is a dual GLP-1/GIP agonist; semaglutide acts only on GLP-1. On ProcedureFinder, GIP (Glucose-dependent Insulinotropic Polypeptide) appears in the Semaglutide for Weight Loss cost guide. Semaglutide is FDA-approved on-label as Wegovy (2021) for chronic weight management and as Ozempic for type 2 diabetes.
How much does semaglutide for weight loss cost? +
Semaglutide for Weight Loss costs $199 to $1,400 per month all-inclusive (medication + provider + supplies) nationally, with a median of $350 in ProcedureFinder's cash-pay benchmarks. Weekly GLP-1 receptor agonist injection that reduces appetite and food cravings, typically producing 12 to 17 percent body weight loss over 12 months.